These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3325948)

  • 1. [Use of plasmapheresis in diseases of the nervous system].
    Ignatowicz R; Michałowicz R; Jóźwiak S; Kmieć T
    Pol Tyg Lek; 1987 Sep; 42(39):1234-7. PubMed ID: 3325948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmapheresis in neurologic diseases].
    Heininger K
    Klin Anasthesiol Intensivther; 1993; 45():169-83. PubMed ID: 8271763
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmapheresis in neurological diseases].
    Giladi N; Harel D
    Harefuah; 1987 Mar; 112(5):241-3. PubMed ID: 3301587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmapheresis in the combined therapy of neurological diseases].
    Piradov MA
    Ter Arkh; 1994; 66(9):72-5. PubMed ID: 7992221
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis--a therapeutic tool in neurological disorders.
    Koski CL
    Md Med J; 1987 Dec; 36(12):1035-7. PubMed ID: 3323758
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of plasmapheresis in the treatment of neuro-immunologic disorders].
    Sanders EA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(34):1469-72. PubMed ID: 3658020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in neurological disease--a year's experience].
    Wirguin I; Shinar E; Abramsky O
    Harefuah; 1988 Sep; 115(5-6):153-5. PubMed ID: 3192126
    [No Abstract]   [Full Text] [Related]  

  • 8. The utility of therapeutic plasmapheresis for neurological disorders. National Institutes of Health.
    Conn Med; 1986 Dec; 50(12):824-8. PubMed ID: 3816223
    [No Abstract]   [Full Text] [Related]  

  • 9. The utility of therapeutic plasmapheresis for neurological disorders.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical use of macromolecular separation (plasmapheresis)].
    Gurland HJ; Samtleben W; Blumenstein M; Randerson DH; Schmidt B
    Lijec Vjesn; 1982; 104(11-12):535-41. PubMed ID: 6985325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmapheresis--therapeutic aspects].
    Wiecek A; Grzeszczak W
    Postepy Hig Med Dosw; 1987; 41(2):152-69. PubMed ID: 3313328
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmapheresis in human therapeutics].
    Kennes B
    Rev Med Brux; 1983 Dec; 4(10):649-57. PubMed ID: 6658248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmapheresis as a method of intensive care in neurology].
    Piradov MA
    Anesteziol Reanimatol; 1996; (2):92-4. PubMed ID: 8754188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic plasmapheresis--current possibilities and prospects].
    Sułek K; Kłos M
    Pol Tyg Lek; 1987 Sep; 42(39):1211-4. PubMed ID: 2964001
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 1996 Sep; 47(3):840-3. PubMed ID: 8797493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasmapheresis; present state and future aspects.
    Gurland HJ; Samtleben W; Blumenstein M
    Life Support Syst; 1983; 1(1):61-70. PubMed ID: 6379316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmapheresis and plasma exchange. Therapeutic indications and risks].
    Fernández García J
    Rev Clin Esp; 1985 Jun; 177(2):47-52. PubMed ID: 3901155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for the application of plasmapheresis (author's transl)].
    Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
    [No Abstract]   [Full Text] [Related]  

  • 19. A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathies.
    Valbonesi M; Montani F; Mosconi L; Zerbi D; Beltramelli A; Florio G
    Haematologia (Budap); 1985; 18(1):33-43. PubMed ID: 3996945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe polyneuropathy in a 3-year-old child after dichlorophenoxyacetic herbicide--chwastox intoxication, treated successfully with plasmapheresis (PF).
    Lankosz-Lauterbach J; Kaczor Z; Kaciński M; Pietrzyk JA; Stec Z
    Przegl Lek; 1997; 54(10):750-2. PubMed ID: 9478100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.